Order Article Reprints

Szempliński S, Kamecki H, Dębowska M, Zagożdżon B, Mokrzyś M, Zawadzki M, Sosnowski R, Tokarczyk A, Poletajew S, Kryst P, et al. Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate. Journal of Clinical Medicine. 2023; 12(1):156. https://doi.org/10.3390/jcm12010156

Szempliński, Stanisław, Hubert Kamecki, Małgorzata Dębowska, Bartłomiej Zagożdżon, Mateusz Mokrzyś, Marek Zawadzki, Roman Sosnowski, Andrzej Tokarczyk, Sławomir Poletajew, Piotr Kryst, and et al. 2023. "Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate" Journal of Clinical Medicine 12, no. 1: 156. https://doi.org/10.3390/jcm12010156

Szempliński, S., Kamecki, H., Dębowska, M., Zagożdżon, B., Mokrzyś, M., Zawadzki, M., Sosnowski, R., Tokarczyk, A., Poletajew, S., Kryst, P., & Nyk, Ł. (2023). Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate. Journal of Clinical Medicine, 12(1), 156. https://doi.org/10.3390/jcm12010156